Basiliximab induction versus no induction in adult heart transplantation.
Katelyn N RudzikRyan M RivosecchiBrittany A PalmerGavin W HickeyJessica H HustonMary E KeeblerDavid J KaczorowskiEdward T HornPublished in: Clinical transplantation (2023)
BAS appears to be associated with greater freedom from rejection without an increase in infections. BAS may be a preferred to a no induction strategy in patients undergoing heart transplantation.
Keyphrases